Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12609000511235Phase 4Not yet recruiting
Phase 4 trial of nicotine in None (2 arms), sponsored by Associate Professor Mark Bellgrove. Primary endpoints: Eriksen Flanker Task performance and Covert Visual Orienting Task performance. Planned start Jun 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12609000511235.